| pubmed-article:2200330 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:2200330 | lifeskim:mentions | umls-concept:C0026769 | lld:lifeskim |
| pubmed-article:2200330 | lifeskim:mentions | umls-concept:C0005477 | lld:lifeskim |
| pubmed-article:2200330 | lifeskim:mentions | umls-concept:C0007806 | lld:lifeskim |
| pubmed-article:2200330 | lifeskim:mentions | umls-concept:C0011900 | lld:lifeskim |
| pubmed-article:2200330 | pubmed:dateCreated | 1990-9-12 | lld:pubmed |
| pubmed-article:2200330 | pubmed:abstractText | The Poser criteria for diagnosing multiple sclerosis (MS) includes clinical, paraclinical and laboratory information. We studied the influence of cerebrospinal fluid (CSF) biochemistry results on the categorisation of patients with suspected MS. A retrospective study was made of 138 patients who had CSF samples sent over a 1 year period to the laboratory for examination for oligoclonal bands. Using the Poser criteria, 23 patients were diagnosed as having definite MS and one patient as probable MS. Cerebrospinal fluid biochemistry upgraded the categorisation from probable to definite MS in 16 of these 24 patients (66%). In this study, we found oligoclonal bands to be more sensitive in the diagnosis of MS (96%) than either the concentration of IgG in the CSF (43.5%) or the IgG expressed as a percentage of the total protein in the CSF (71%). We conclude that CSF biochemistry is a valuable investigation in the evaluation of patients with suspected MS. | lld:pubmed |
| pubmed-article:2200330 | pubmed:language | eng | lld:pubmed |
| pubmed-article:2200330 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2200330 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:2200330 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2200330 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2200330 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2200330 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:2200330 | pubmed:month | May | lld:pubmed |
| pubmed-article:2200330 | pubmed:issn | 0004-5632 | lld:pubmed |
| pubmed-article:2200330 | pubmed:author | pubmed-author:DeanGG | lld:pubmed |
| pubmed-article:2200330 | pubmed:author | pubmed-author:DavisSS | lld:pubmed |
| pubmed-article:2200330 | pubmed:author | pubmed-author:ByromHH | lld:pubmed |
| pubmed-article:2200330 | pubmed:author | pubmed-author:KilpatrickTT | lld:pubmed |
| pubmed-article:2200330 | pubmed:author | pubmed-author:TressBB | lld:pubmed |
| pubmed-article:2200330 | pubmed:author | pubmed-author:RatnaikeSS | lld:pubmed |
| pubmed-article:2200330 | pubmed:author | pubmed-author:KilpatrickCC | lld:pubmed |
| pubmed-article:2200330 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:2200330 | pubmed:volume | 27 ( Pt 3) | lld:pubmed |
| pubmed-article:2200330 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:2200330 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:2200330 | pubmed:pagination | 195-8 | lld:pubmed |
| pubmed-article:2200330 | pubmed:dateRevised | 2004-11-17 | lld:pubmed |
| pubmed-article:2200330 | pubmed:meshHeading | pubmed-meshheading:2200330-... | lld:pubmed |
| pubmed-article:2200330 | pubmed:meshHeading | pubmed-meshheading:2200330-... | lld:pubmed |
| pubmed-article:2200330 | pubmed:meshHeading | pubmed-meshheading:2200330-... | lld:pubmed |
| pubmed-article:2200330 | pubmed:meshHeading | pubmed-meshheading:2200330-... | lld:pubmed |
| pubmed-article:2200330 | pubmed:meshHeading | pubmed-meshheading:2200330-... | lld:pubmed |
| pubmed-article:2200330 | pubmed:meshHeading | pubmed-meshheading:2200330-... | lld:pubmed |
| pubmed-article:2200330 | pubmed:meshHeading | pubmed-meshheading:2200330-... | lld:pubmed |
| pubmed-article:2200330 | pubmed:meshHeading | pubmed-meshheading:2200330-... | lld:pubmed |
| pubmed-article:2200330 | pubmed:meshHeading | pubmed-meshheading:2200330-... | lld:pubmed |
| pubmed-article:2200330 | pubmed:meshHeading | pubmed-meshheading:2200330-... | lld:pubmed |
| pubmed-article:2200330 | pubmed:meshHeading | pubmed-meshheading:2200330-... | lld:pubmed |
| pubmed-article:2200330 | pubmed:meshHeading | pubmed-meshheading:2200330-... | lld:pubmed |
| pubmed-article:2200330 | pubmed:meshHeading | pubmed-meshheading:2200330-... | lld:pubmed |
| pubmed-article:2200330 | pubmed:year | 1990 | lld:pubmed |
| pubmed-article:2200330 | pubmed:articleTitle | Cerebrospinal fluid biochemistry in the diagnosis of multiple sclerosis. | lld:pubmed |
| pubmed-article:2200330 | pubmed:affiliation | Department of Biochemistry, Royal Melbourne Hospital, Parkville, Victoria, Australia. | lld:pubmed |
| pubmed-article:2200330 | pubmed:publicationType | Journal Article | lld:pubmed |
